Brain Mapping Instruments Market Study Explores Industry Growth Toward $3.33 Billion

The brain mapping instruments market is on the cusp of impressive growth, driven by advancements in neuroimaging technology and expanding clinical applications. As healthcare continues to prioritize precision and personalized treatment, the demand for sophisticated brain mapping tools is escalating rapidly. Let's explore the market's size, key players, emerging trends, and the main segments shaping this evolving industry.

Projected Expansion of the Brain Mapping Instruments Market by 2030
The brain mapping instruments market is expected to experience substantial growth, reaching a value of $3.33 billion by 2030. This growth is projected at a compound annual growth rate (CAGR) of 6.6%. Key factors propelling this expansion include increasing demand for functional brain mapping through fMRI and PET technologies, the rising adoption of hybrid and high-resolution imaging systems, and more widespread use of non-invasive mapping techniques in outpatient environments. Moreover, the integration of multimodal brain analysis tools and growing applications in precision medicine and neurotherapeutics also contribute significantly. Prominent trends forecasted during this period involve advanced neuroimaging adoption, enhanced brain activity monitoring, expanded roles of brain mapping in neuroscience and cognitive studies, and a strong preference for patient-friendly, non-invasive methods. Emphasis on improving imaging accuracy, data quality, and diagnostic efficiency further supports market growth.

Download a free sample of the brain mapping instruments market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18270&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Influencing the Brain Mapping Instruments Market
Several major corporations lead the brain mapping instruments market, including Siemens Healthineers, GE Healthcare, Philips Healthcare, Elekta AB, Nihon Kohden Corporation, Brainlab AG, and Natus Medical Incorporated. Other significant players include Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, and Gowerlabs Ltd.

Notably, in May 2025, Firefly Neuroscience, Inc., a US-based AI firm specializing in brain health solutions, acquired Evoke Neuroscience, Inc. for $6 million. This strategic move greatly expanded Firefly's proprietary EEG/ERP brain-wave database, strengthened its patent portfolio, and broadened its commercial reach. Evoke Neuroscience is recognized for its hardware and software designed for comprehensive EEG/ERP-based brain health assessments.

View the full brain mapping instruments market report:
https://www.thebusinessresearchcompany.com/report/brain-mapping-instruments-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Innovations Reshaping the Brain Mapping Instruments Market
Industry leaders are focusing heavily on sensing-enabled adaptive neuromodulation technologies. A prime example is BrainSense-enabled closed-loop deep brain stimulation (DBS), which integrates real-time brain signal monitoring to customize stimulation therapy dynamically. This neuro-interface embedded in DBS devices records local field potentials (LFPs) from targeted brain regions, processes the data, and adjusts electrical stimulation in response to neural activity, thereby optimizing therapeutic outcomes while minimizing side effects.

For instance, in February 2025, Medtronic, a US-based medical technology company, launched its BrainSense Adaptive DBS system after receiving FDA approval. This system features real-time self-adjusting stimulation, a BrainSense Electrode Identifier designed to quickly find the optimal electrode contact, and closed-loop personalized therapy that adapts seamlessly both in clinical environments and during patients' everyday activities.

Main Segments Defining the Global Brain Mapping Instruments Market
The brain mapping instruments market is categorized into several primary segments:

1) By Product Type:
- Computed Axial Tomography (CAT)
- Positron Emission Tomography (PET)
- Electroencephalography (EEG)
- Functional Near-Infrared Spectroscopy (FNIRS)
- Functional Magnetic Resonance Imaging (FMRI)
- Other Products

2) By Procedure Type:
- Devices for Invasive Procedures
- Devices for Non-invasive Procedures

3) By End User:
- Hospitals
- Ambulatory Centers

Further sub-segments provide a more detailed breakdown:
- CAT includes conventional, high-resolution, and portable CT scanners.
- PET comprises standalone PET scanners, hybrid PET/CT scanners, and PET/MRI scanners.
- EEG is divided into digital EEG systems, ambulatory EEG systems, and video EEG monitoring systems.
- FNIRS consists of continuous wave, frequency domain, and hybrid systems.
- FMRI covers resting-state, task-based modalities, and high-field MRI systems.
- Other products encompass magnetoencephalography (MEG) systems, near-infrared spectroscopy (NIRS) devices, and transcranial magnetic stimulation (TMS) systems.

This segmentation provides a comprehensive framework to understand the diverse technologies and applications driving the brain mapping instruments market forward.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.